KA
FTXH icon

Kovack Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Kovack Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,380
Closed -$243K – 719
2021
Q2 		$243K Buy
9,380
+120
+1% +$3.1K 0.03% 576
2021
Q1 		$237K Buy
+9,260
New +$243K 0.03% 534

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JAWM
J. Arnold Wealth Management Youngstown, Ohio $294M AUM 33.6% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovack Advisors's FTXH Position: Q3 2021 in Review

Kovack Advisors sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2021, closing a stake of 9,380 shares — an estimated $243K sold.

Kovack Advisors first reported a position in FTXH in Q1 2021 and held it in 2 quarters. The position peaked at $243K in Q2 2021. 16 funds tracked by Wall St. Rank hold FTXH as of Q3 2021.

  • Kovack Advisors reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q3 2021 after selling out during the quarter.
  • Kovack Advisors sold 9,380 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2021, an estimated $243K.
  • Kovack Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2021 and held it in 2 quarters.
  • Kovack Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $243K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2021.

Based on Kovack Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.